Aminoglycoside Antibacterial [EPC]

30424 reported adverse events

Drugs of this class: TOBRAMYCIN TOBRAMYCIN AND DEXAMETHASONE TOBRAMYCIN INHALATION SOLUTION AMIKACIN GENTAMICIN, PREDNISOLONE ACETATE LOTEPREDNOL ETABONATE AND TOBRAMYCIN TOBRAMYCIN / DEXAMETHASONE TOBRAMYCIN INHALATION TOBRAMYCIN OPHTHALMIC SOLUTION

These side effects are most commonly reported by patients taking drugs of the Aminoglycoside Antibacterial [EPC] class:

# Side effect Count
0 OFF LABEL USE 2225
1 DEATH 1938
2 DYSPNOEA 1914
3 COUGH 1827
4 PNEUMONIA 1487
5 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1479
6 DRUG INEFFECTIVE 1417
7 HOSPITALISATION 1094
8 CONDITION AGGRAVATED 1090
9 CYSTIC FIBROSIS 1083
See all common reactions for Aminoglycoside Antibacterial [EPC]

Drugs of the Aminoglycoside Antibacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AQUEOUS FIBRIN 24 0.4898
1 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1479 0.3196
2 CYSTIC FIBROSIS LUNG 32 0.3137
3 CYSTIC FIBROSIS RELATED DIABETES 25 0.3086
4 CYSTIC FIBROSIS 1083 0.2469
5 CHOROIDITIS 55 0.2132
6 MYCOBACTERIUM ABSCESSUS INFECTION 82 0.2130
7 INFECTIVE EXACERBATION OF BRONCHIECTASIS 37 0.1927
8 GEOTRICHUM INFECTION 29 0.1790
9 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 127 0.1698
See all enriched reactions for Aminoglycoside Antibacterial [EPC]